IonLAST™, a novel hand sanitizer, kills germs on contact and, unlike common hand sanitizers, provides protection against their transmission for more than four hours after applying to skin.
A Stanford University spinout is joining the small army of biotech companies trying to find drugs for amyotrophic lateral sclerosis (ALS).
Tranquis Therapeutics are committed to the discovery and development of innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases.
The companies will evaluate novel formulations of drugs that have been notoriously difficult to formulate and deliver into the skin.
BioWorld: Drug developers’ Golden Ticket, worth a lot more than a tour of a candy manufacturing plant
Bacchus Therapeutics and PTM Therapeutics have each won a 2020 AbbVie Golden Ticket at MBC BioLabs.
Read online article at BUSINESS WIRE San Francisco, Calif., April 21, 2020 /BUSINESS WIRE -- Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around a [...]
AMGEN is accepting submissions for the Golden Ticket through June 24, 2020